Analysis of blood clotting with the total thrombus analysis system in healthy dogs. (March 2021)

• Record Type: Journal Article
• Authors: Iwanaga, Tomoko; Fukushima, Ryuji; Nagasato, Tomoka; Maruyama, Ikuro; Miura, Naoki
• Is Part Of: Journal of veterinary diagnostic investigation. Volume 33:Number 2(2021)
• Page Start: 357
• Page End: 361
• Publication Date: 2021-03
• Subjects: acetylsalicylic acid -- dalteparin -- dogs -- low-molecular-weight heparin -- microflow-chamber system; Veterinary medicine -- Diagnosis -- Periodicals; 636.0896075
• DOI: 10.1177/1040638721991862
• Languages: English
• ISSNs: 1040-6387

Abstract

To date, coagulation tests are unable to reflect in vivo coagulation status in the same system, including platelet function, fibrin clot formation, and whole blood flow. The Total Thrombus Analysis System (T-TAS), which is a microfluidic assay that simulates conditions in vivo, measures whole blood flow at defined shear rates under conditions designed to assess platelet function (PL-chip) or coagulation and fibrin clot formation (AR-chip). The T-TAS records occlusion start time, occlusion time, and area under the curve. We evaluated this test in healthy control dogs. We also investigated the effect in vivo of acetylsalicylic acid (ASA), and the effect in vitro of an anticoagulation drug (dalteparin; low-molecular-weight heparin; LMWH). The CV of the AUC of both chips was good (CVs of 6.45% [PL] and 1.57% [AR]). The inhibition of platelet function by ASA was evident in the right-shift in the PL test pressure curve. The right-shift in the AR test pressure curves showed that the administration of LMWH inhibited both platelets and the coagulation cascade. The T-TAS may be useful in the evaluation of canine blood coagulation.